Compare AEIS & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AEIS | RDY |
|---|---|---|
| Founded | 1981 | 1984 |
| Country | United States | India |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8B | 11.6B |
| IPO Year | 1996 | 2001 |
| Metric | AEIS | RDY |
|---|---|---|
| Price | $331.23 | $14.49 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 1 |
| Target Price | ★ $274.27 | $16.90 |
| AVG Volume (30 Days) | 690.1K | ★ 1.8M |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | 0.12% | ★ 0.49% |
| EPS Growth | ★ 168.53 | N/A |
| EPS | ★ 3.84 | N/A |
| Revenue | ★ $453,095,000.00 | N/A |
| Revenue This Year | $21.03 | $7.50 |
| Revenue Next Year | $12.86 | $2.96 |
| P/E Ratio | $86.26 | ★ $18.67 |
| Revenue Growth | ★ 38.39 | N/A |
| 52 Week Low | $75.01 | $12.26 |
| 52 Week High | $334.53 | $16.17 |
| Indicator | AEIS | RDY |
|---|---|---|
| Relative Strength Index (RSI) | 79.78 | 59.51 |
| Support Level | $302.01 | $14.06 |
| Resistance Level | $328.37 | $14.53 |
| Average True Range (ATR) | 16.17 | 0.25 |
| MACD | 3.93 | 0.05 |
| Stochastic Oscillator | 98.30 | 84.82 |
Advanced Energy Industries Inc provides precision power-conversion measurement and control solutions that transform power into various forms for use in manufacturing and industrial equipment and applications. The firm serves original equipment manufacturers and end customers in the semiconductor, flat panel display, solar panel, and other industrial capital equipment markets. Products include thin-film power-conversion systems, which control and modify raw electrical power into a customizable, predictable power source, and power control modules, which control and measure temperature during manufacturing cycles. A majority of the firm's revenue is generated in United States, with the rest from Mexico, Taiwan, China and All others.
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.